[go: up one dir, main page]

NO863671D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.

Info

Publication number
NO863671D0
NO863671D0 NO863671A NO863671A NO863671D0 NO 863671 D0 NO863671 D0 NO 863671D0 NO 863671 A NO863671 A NO 863671A NO 863671 A NO863671 A NO 863671A NO 863671 D0 NO863671 D0 NO 863671D0
Authority
NO
Norway
Prior art keywords
heterocycloylkylpyrido
indoles
procedure
preparation
therapeutic active
Prior art date
Application number
NO863671A
Other languages
English (en)
Other versions
NO163619C (no
NO163619B (no
NO863671L (no
Inventor
Magid Abdel-Megid Abou-Gharbia
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO863671D0 publication Critical patent/NO863671D0/no
Publication of NO863671L publication Critical patent/NO863671L/no
Publication of NO163619B publication Critical patent/NO163619B/no
Publication of NO163619C publication Critical patent/NO163619C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO863671A 1985-09-16 1986-09-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler. NO163619C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/776,180 US4636563A (en) 1985-09-16 1985-09-16 Antipsychotic γ-carbolines

Publications (4)

Publication Number Publication Date
NO863671D0 true NO863671D0 (no) 1986-09-15
NO863671L NO863671L (no) 1987-03-17
NO163619B NO163619B (no) 1990-03-19
NO163619C NO163619C (no) 1990-06-27

Family

ID=25106686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863671A NO163619C (no) 1985-09-16 1986-09-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler.

Country Status (28)

Country Link
US (1) US4636563A (no)
EP (1) EP0223344B1 (no)
JP (1) JPS6267083A (no)
KR (1) KR900002245B1 (no)
CN (1) CN1013864B (no)
AR (1) AR242208A1 (no)
AT (1) ATE55770T1 (no)
AU (1) AU590605B2 (no)
CA (1) CA1275099A (no)
CY (1) CY1595A (no)
DE (1) DE3673607D1 (no)
DK (1) DK440686A (no)
EG (1) EG18015A (no)
ES (1) ES2002656A6 (no)
FI (1) FI83318C (no)
GB (1) GB2180536B (no)
GR (1) GR862343B (no)
HK (1) HK53491A (no)
HU (1) HU195217B (no)
IL (1) IL79956A0 (no)
MX (1) MX3681A (no)
NO (1) NO163619C (no)
NZ (1) NZ217580A (no)
PH (1) PH22515A (no)
PT (1) PT83344B (no)
SU (1) SU1442074A3 (no)
YU (1) YU45023B (no)
ZA (1) ZA866258B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328905A (en) * 1987-07-20 1994-07-12 Duphar International Research B.V. 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives
US5360800A (en) * 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
HU207078B (en) * 1988-08-02 1993-03-01 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
JPH02167280A (ja) * 1988-08-15 1990-06-27 Glaxo Group Ltd ラクタム誘導体
US5021569A (en) * 1990-06-12 1991-06-04 American Home Products Corporation 4-azatricyclo[4.3.1.1(3,8)]undecylarylpiperazines with anxiolytic activity
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
FR2715659B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivés de 3-(2-aminoéthyl)-4-[3-(trifluorométhyl)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique.
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3,4-二氢-2h-1,4-苯并噁嗪衍生物、制备及其应用
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
EP0905136A1 (en) * 1997-09-08 1999-03-31 Janssen Pharmaceutica N.V. Tetrahydro gamma-carbolines
RU2283108C2 (ru) * 2003-12-08 2006-09-10 Сергей Олегович Бачурин ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
US20070179174A1 (en) * 2003-12-08 2007-08-02 Bachurin Sergei O Methods and compositions for slowing aging
AU2006275694A1 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1H-pyrido(4,3,b)indoles as serotonin receptor agonists and antagonists
CA2624731A1 (en) * 2005-10-04 2007-04-12 Medivation, Inc. Hydrogenated pyrido-indole compounds for the treatment of huntington's disease
RU2338537C2 (ru) * 2006-01-25 2008-11-20 Сергей Олегович Бачурин СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670010A1 (de) * 1966-12-07 1970-07-30 Abbott Lab Aroylalkylderivate von 1,2,3,4-Tetrahydro-5H-pyride-[4,3b]-indolen und Verfahren zur Herstellung derselben
US3502688A (en) * 1968-09-10 1970-03-24 Hoffmann La Roche 5-(4-pyridylethyl)-pyridoindole derivatives
US3522262A (en) * 1968-09-10 1970-07-28 Hoffmann La Roche 5-(pyridylalkyl)-pyridoindole derivatives
DE1952800C3 (de) * 1969-10-20 1974-04-18 Nautschno-Issledowatelskij Institut Farmakologii I Chimioterapii, Moskau 3,6-Dimethyl-l,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
DE2621729A1 (de) * 1976-05-15 1977-12-08 Boehringer Sohn Ingelheim Neue 2-(4-phenyl-4-cyanobutyl)-1,2, 3,4-tetrahydro-5(h)-pyrido- eckige klammer auf 4,3-b eckige klammer zu -indole und verfahren zu ihrer herstellung
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
NZ226032A (en) * 1987-09-03 1991-12-23 Glaxo Group Ltd 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions

Also Published As

Publication number Publication date
ATE55770T1 (de) 1990-09-15
MX3681A (es) 1993-10-01
EP0223344B1 (en) 1990-08-22
GB8621226D0 (en) 1986-10-08
JPS6267083A (ja) 1987-03-26
NZ217580A (en) 1988-07-28
ZA866258B (en) 1988-04-27
NO163619C (no) 1990-06-27
AR242208A1 (es) 1994-08-31
DK440686A (da) 1987-03-17
CN86106194A (zh) 1987-03-18
CN1013864B (zh) 1991-09-11
ES2002656A6 (es) 1988-09-16
FI863692L (fi) 1987-03-17
CA1275099A (en) 1990-10-09
EP0223344A1 (en) 1987-05-27
FI83318B (fi) 1991-03-15
KR900002245B1 (ko) 1990-04-07
GR862343B (en) 1987-01-12
YU157686A (en) 1988-04-30
PH22515A (en) 1988-09-12
CY1595A (en) 1992-04-03
HUT42478A (en) 1987-07-28
DE3673607D1 (en) 1990-09-27
FI863692A0 (fi) 1986-09-12
US4636563A (en) 1987-01-13
HK53491A (en) 1991-07-19
PT83344A (pt) 1986-10-01
KR870003103A (ko) 1987-04-15
EG18015A (en) 1991-08-30
DK440686D0 (da) 1986-09-15
IL79956A0 (en) 1986-12-31
PT83344B (pt) 1988-07-29
GB2180536A (en) 1987-04-01
FI83318C (fi) 1991-06-25
AU590605B2 (en) 1989-11-09
SU1442074A3 (ru) 1988-11-30
NO163619B (no) 1990-03-19
YU45023B (en) 1991-06-30
NO863671L (no) 1987-03-17
GB2180536B (en) 1989-04-05
HU195217B (en) 1988-04-28
AU6181386A (en) 1987-03-19

Similar Documents

Publication Publication Date Title
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO870075D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.